Santen Pharmaceutical Co., Ltd. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SNPHY Over the counter 2834 www.santen.com/en

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical (TSE:4536) Stock Could Be Undervalued On Current Earnings - Oct 18th, 2026 6:20 pm
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability - Oct 1st, 2026 6:00 am
Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million - Sep 22nd, 2026 5:00 am
RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1% - Jan 8th, 2026 5:00 am